-
US FDA awards orphan drug designation to Minoryx’s MIN-102 compound
pharmaceutical-technology
February 27, 2017
The US Food and Drug Administration (FDA) has granted orphan drug designation to Minoryx Therapeutics’ lead compound MIN-102.
-
Minoryx Therapeutics receives Orphan Drug Designation for its lead candidate MIN-102
biospectrumasia
February 24, 2017
MIN-102 targets X-linked Adrenoleukodystrophy (X-ALD), a life threatening orphan CNS disease with high unmet medical need
-
European Commission Grants Orphan Drug Designation to Cabiralizumab (FPA008) for Pigmented Villonodu
firstwordpharma
January 25, 2017
Five Prime Therapeutics, Inc. (Nasdaq:FPRX) today announced that the European Commission has granted orphan designation for cabiralizumab (FPA008) for the treatment of tenosynovial giant cell tumour.
-
TG Therapeutics Announces Orphan Drug Designation for the Combination of TG-1101 and TGR-1202 for th
firstwordpharma
January 25, 2017
TG Therapeutics, Inc. (NASDAQ:TGTX) today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation covering the combination of TG-1101 (ublituximab).
-
Therabron Therapeutics Receives Orphan Drug Designation in the European Union for CG367, Indicated f
firstwordpharma
January 24, 2017
Therabron Therapeutics, Inc., announced that the European Medicines Agency (EMA) Committee for Orphan Medicinal Products has granted Orphan Drug Designation for Therabron's CG367 program, indicated for the treatment of Bronchiolitis Obliterans Syndrome (B
-
Concert Pharmaceuticals receives FDA orphan drug designation for CTP-656 for the treatment of CF
cphi-online
January 24, 2017
Topline results from the Phase II trial are expected by year-end 2017.
-
US FDA grants orphan drug designation to Yisheng Biopharma’s PIKA rabies vaccine
pharmaasia
January 22, 2017
Currently under Phase II clinical development, the orphan drug designation is an important milestone for Yisheng Biopharma.